Goldman Sachs raised the firm’s price target on Oracle (ORCL) to $195 from $145 and keeps a Neutral rating on the shares. The company’s revenue and operating margins for Q4 topped estimates, but while its aggressive investment in CapEx is a welcome evidence of strong demand, the firm also questions whether the $25B in FY26 will be enough, noting that the ramping depreciation may constrain potential earnings power over the mid-term, especially if revenue growth targets prove aspirational, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL: